 |
 |
In a message dated 97-09-30 17:44:08 EDT, you write: << the mfg of >Eldepryl. It states " There is no evidence from controlled studies that selegiline has any beneficial effect in the absence of concurrent levodopa therapy." >> This is no negative statement about the drug; it is simply not making claims unsupported by the clinical evidence. My Barbara could not tolerate it, and after a trial period had to give it up. Chere Fleurette: Welcome back! and be most cautious. Ces medicaments sont puissants et pas toujours efficace! Be well and Carpe Diem Michel Margosis